Ribeirao Preto, Brazil

Andre Messias

This inventor holds 1 USPTO granted patent. Top assignee: Okuvision Gmbh. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Andre Messias in Eye Treatment

Introduction

Andre Messias is an accomplished inventor based in Ribeirao Preto, Brazil. He has made significant contributions to the field of medical technology, particularly in the treatment of eye conditions. His innovative approach combines personalized medicine with advanced electrical stimulation techniques.

Latest Patents

One of Andre Messias's notable patents is a method for treating at least one eye of a patient in need of such treatment with a pulsed electrical stimulation signal. In this method, an individual parameter of the patient is first determined. Subsequently, at least one stimulation parameter of the pulsed electrical stimulation signal is set based on the individual parameter. Finally, the pulsed electrical stimulation signal is applied to the eye, showcasing a tailored approach to eye treatment. He holds 1 patent for this innovative method.

Career Highlights

Andre Messias is currently associated with Okuvision GmbH, a company dedicated to advancing eye care technologies. His work at Okuvision reflects his commitment to improving patient outcomes through innovative solutions.

Collaborations

Throughout his career, Andre has collaborated with notable professionals in the field, including Florian Gekeler and Walter G. Wrobel. These collaborations have further enriched his research and development efforts.

Conclusion

Andre Messias's contributions to eye treatment through his patented method exemplify the intersection of innovation and healthcare. His work continues to inspire advancements in medical technology, ultimately benefiting patients in need of effective eye treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…